A s shown for the matrix Gla protein, 1,2 osteopontin, 3, 4 and others-in human genetic and animal studies-osteoprotegerin (OPG) has been reported to be involved in the development of vascular calcification/atherosclerotic phenotypes. [5] [6] [7] Increased OPG serum levels have been reported to be significantly related to cardiovascular disease (CVD) phenotypes, 8 and in apparently healthy individuals, with an increased future risk of coronary events. 9 Genetic variation at the human OPG gene locus has been associated with colorectal 10 /prostate cancer risk 11 and bipolar disorders 12 in whole genome approaches; in single variant analyses, OPG T-159C has been associated with elevated OPG serum levels, 13 CVD, 13, 14 intima media thickness, and reduced maximal forearm blood flow in healthy subjects. 15 The human OPG gene (8q24) consists of 5 exons and 4 introns, and is transcribed into 4 transcripts (2.4 kb, 3.0 kb, 4.2 kb, and 6.5 kb in lengths). The 2.4-kb form represents the major transcript and originates from transcriptional initiation from a TATA box 30 bp upstream of the transcription start site (TSS). Whereas the 3.0-kb transcript is derived from the alternative use of TSS, the 4.2-kb and 6.5-kb transcripts result from alternative splicing events. 16 Because little is known about the structural architecture or functional aspects of the OPG promoter region, we (1) reanalyzed putative TSS in osteosarcoma cell lines SaOs-2 and U2Os by rapid amplification of 5Ј cDNA Ends (5Ј RACE); (2) directly sequenced 1008 bp of the OPG 5Јflanking region in a set of 114 chromosomes of patients with CVD to identify positions of single-nucleotide polymorphisms (SNPs); (3) determined the presence of molecular haplotypes (MolHaps) by individual DNA subcloning; and (4) performed molecular and functional profiling assays using reporter gene experiments, bandshift assays, chromatin immunoprecipitation (ChIP) assays, and coexpression analyses in 2 different cell lines.
Methods

Study Populations
The current investigation was based on the Münster Molecular Functional Profiling for Mechanism Detection (MolProMD) Study, 17 a running study of CVD patients (MI, essential hypertension). The study was approved by the ethics committee of the Medical Faculty, Westfälische Wilhelms University of Münster, and written informed consent was obtained from all study subjects.
Identification of OPG Promoter Variants and Molecular Haplotypes
Genomic DNA was prepared from white blood cells (Qiagen), and 1008 bp of the 5Ј-flanking region of the OPG locus were scanned for genetic variation by sequencing both DNA strands (ABI Prism 3770, Perkin Elmer). Two hundred forty-nine bp and 275 bp of the promoter region (Acc# AB008822; harboring T-960C, A-946G, G-900A, T-864G, or T-159C) of genomic DNA from 57 CVD patients were amplified, subcloned, and sequenced twice.
In Silico Analyses of Putative Transcription Factor Binding Sites
All identified SNPs were subjected to computer-aided analyses using AliBaba 2.1 (www.gene-regulation.com), 18 a position weight matrix algorithm, predicting physical transcription factor binding sites (TFBS) in a given DNA sequence based on the TRANSFAC database of eukaryotic transcription factors (TFs; TRANSFAC 10).
Cell Culture
Detailed protocols on the human osteosarcoma cell lines SaOs-2 and U2Os are presented in the supplemental materials (available online at http://atvb.ahajournals.org). For the identification of endogenously OPG expressing cells, semiquantitative PCR using cDNA from different cell lines was performed.
Rapid Amplification of 5 RACE
5Ј RACE was performed as described previously 19 using RNA extracted from SaOs-2 and U2Os cells.
ChIP Assay
ChIP was performed as described previously, 17, 20 using specific antibodies against specificity protein 1 (Sp1), nuclear factor-1 (NF-1), and early growth response factor-1 (Egr1).
Reporter Gene Constructs and Transient Transfections
The plasmids pOPG-MolHap1/luc, pOPG-MolHap2/luc, and pOPG-MolHap4/luc as well as the deletion constructs were constructed following standard cloning procedures. All reporter gene constructs were transfected in SaOs-2 and U2Os cells using Effectene transfection reagent (Qiagen).
Electrophoretic Mobility Shift Assay
Nuclear protein extracts were harvested by a modified procedure of the protocol published by Schreiber et al. 21 To cover the promoter portion comprising T-960C, A-946G, G-900A, T-864G, a 154-bp fragment was amplified by PCR using GoTaq (Promega) and primers 5Ј-ACCACACTTTACAAGTCATCAAG-3Ј (sense) and 5Ј-TTCCTACGCGCTGAACTTC-3Ј (antisense). A 72-bp fragment, representing the cis-active element, was amplified by PCR using GoTaq (Promega) and primers 5Ј-ACCACACTTTACAAGTCATCAAG-3Ј (sense) and 5Ј-CTCTAGGGTTCGCTGTCT-3Ј (antisense). Doublestranded probes, harboring either MolHap1, 2, or 4, were 3Ј-biotinylated using biotin-16-ddUTP (Roche). Electrophoretic mobility shift assays (EMSEs) were performed using the LightShift Chemiluminescent EMSE kit (Thermo Fisher).
A detailed description of all methods is provided in the supplemental material.
Results
Endogenous OPG mRNA Expression and Determination of TSS
Using different stimulatory regimes, OPG mRNA expression was detectable in both SaOs-2 and U2Os cells (supplemental Figure IA ). Using 5Ј RACE, we identified 2 TSS in both cell lines; TSS1 being located 64 bp upstream of the ATG codon, and TSS2 225 bp upstream of the ATG codon. We confirmed these results by diacritic PCR with specific primers, located directly at the respective TSS. Compared to TSS2 (2.4-kb transcript), which was used to a lesser extent, TSS1 (2.4-kb transcript) was equally and quantitatively used in both cell lines. We defined a third TSS (Ϸ3.0-kb transcript), 667 bp upstream of the ATG codon by diacritic PCR in both cell lines, which was used as frequently as TSS1 in SaOs-2 but slightly less than TSS1 in U2Os. As TSS1 is usually described as major TSS, positions of SNPs are indicated relative to this site ( Figure 1 ). 
Identification of OPG Gene Variants and MolHaps
Ϫ900A, and Ϫ864G were always transmitted together. To define cis-active elements, we designed serial deletion constructs by 5Ј-truncation (supplemental Figure II) .
In silico analyses of MolHaps 1, 2, and 4 using AliBaba 2.1 predicted several TFBS, some of which were altered in the presence of nucleotide substitutions (supplemental Figure  IB 
] showed a consensus sequence similarity to NF-B.
Transcriptional Activity of the OPG 5-Flanking Region
The reporter vector pOPG-Del1/luc represents the full-length construct (1008 bp) with MolHap1 sequence In both cell lines transcription is driven from TSS1, TSS2, and TSS3. Intactness of cDNA was ascertained with specific primers for hRP27 (TSS, transcription start site).
transcriptional activity in SaOs-2. Truncation of 85 bp (Ϫ1020/Ϫ936) resulted in a complete abrogation of transcriptional activity (pOPG-Del2/luc, PϽ0.0001). Further truncated constructs pOPG-Del3/luc (Ϫ936/Ϫ677) and pOPG-Del4/luc (Ϫ677/Ϫ287) did not restore activity. We subsequently introduced the identified SNPs in the context of the MolHaps into both full-length and deletion constructs ( Figure 3 ). In SaOs-2, the activity of the MolHap1 full-length construct was significantly decreased for MolHap2 (OPG-D1H2, Pϭ0.0014), and MolHap4 (OPG-D1H4, PϽ0.0001). Transcriptional activities were significantly decreased for MolHaps1 and 2, when the Ϫ159C allele was introduced into the respective full-length constructs (OPG-Del1-159c, PϽ0.0001; OPG-D1H2-159c, Pϭ0.0058). Presence of the Ϫ159C allele resulted in a nonsignificant decrease of transcriptional activity of MolHap4 (OPG-D1H4 -159c, Pϭ0.2749; Figure 3 ). Introduction of the Ϫ159C allele into the truncated constructs ( Figure 4 ) increased transcriptional activity (OPG-Del2-159c, Pϭ0.0005). Similar results were obtained for deletion constructs OPG-Del3 and OPG-Del4 (Figure 4 ). Transcriptional activities of the full-length and deletion constructs were similar in U2Os cells (supplemental Figure III and IV) .
To investigate the transcriptional activity of the three MolHaps separately, we linked the Ϫ1020/Ϫ772 portion of the human OPG 5Ј-flanking region to the reporter gene vector ptk81-luc3, which contains a minimal promoter allowing for the assembly of the transcriptional machinery, with only very little remnant activity. In both cell lines, MolHap1 displayed poor transcriptional activity, being as active as the mock vector ptk81-luc3 (supplemental Figure VC) . A highly significant decrease of transcriptional activity occurred for MolHap2 (SaOs-2, Pϭ0.0027; U2Os, PϽ0.0001) and Mol-Hap4 (SaOs-2, Pϭ0.0097; U2Os, Pϭ0.0006). This isolated promoter portion comprising the 3 MolHaps appeared to be poorly involved in the transcriptional regulation of OPG.
Bandshift Assays
OPG MolHaps
SaOs-2 nuclear extracts revealed a specific shift for all 3 MolHaps ( Figure 5A, left) , being less pronounced for Mol-Haps2 and 4 (black arrow). An additional weak band was visible for MolHap2 and MolHap4, being competed with the unlabeled PCR fragment (open arrows). Because in silico analyses predicted altered binding sites for Sp1 and NF-1 (supplemental Figure IB) , we performed EMSAs using the consensus sites as competitors ( Figure 5A, right panel) . The prominent band (black arrow) was competed for all 3 Mol-Haps by NF-1, but not by Sp1 consensus oligos. The additional binding pattern for MolHap2 and MolHap4 (open arrows) was competed by a Sp1 consensus site. Because 5Ј-truncation of 84 bp (Ϫ1020/Ϫ936) resulted in significantly decreased transcriptional activity, this portion was also subjected to EMSA ( Figure 5B ). We detected 3 specific shifts for all 3 MolHaps in SaOs-2, being competed with the homologue unlabeled probe. Whereas 2 of the shifted bands were competed by Sp1 consensus sites (black arrows), 1 was competed by NF-1 consensus sites (white arrow). ChIP assays with specific antibodies against Sp1, Egr1, and NF-1 
OPG T-159C
EMSAs performed with SaOs-2 nuclear extracts resulted in an allele-specific shift for Ϫ159T only (Figure 6A, left) . Because Sp1 and Egr1 are grouped in "clusters" of TFBS 68 bp upstream of T-159C (supplemental Figure IB) , EMSAs were performed using Sp1 and Egr1 consensus sites as competitor. The prominent Ϫ159T binding pattern was competed with an Egr1 consensus site, but not with a Sp1 consensus site ( Figure 6A, right panel) . A recombinant Egr1 binding domain was found to specifically bind to the Ϫ159T allele (supplemental Figure VIIB) . ChIP assays with specific antibodies against Sp1, Egr1, and NF-1 revealed binding of Sp1 and NF-1 (supplemental Figure VIIIB, left) . Similar results were obtained with U2Os nuclear extracts (supplemental Figure VI-VIII) .
A detailed description of all results is provided in the supplemental material.
Discussion
As genome-wide approaches to identify previously unexpected loci associated with complex disease phenotypes still fail to disclose specific functional effects of genetic variation at the proposed locus, 22,23 a reliable molecular profiling of genetic variation and a better knowledge of the molecular/ functional structure of the locus of interest is mandatory. Our aim was to analyze the transcriptional organization of the (polymorphic) OPG promoter and the impact of previously unpublished individual MolHaps on its activity. We were able to identify 1 novel TSS 225 bp upstream of the ATG codon, and subsequently defined a TSS 64 bp upstream of the ATG codon very close to the major TSS described by Morinaga et al, 16 reporting a TSS 67 bp upstream of the ATG codon by primer extension with [␥-32 P]dCTP end-labeled primers. Given the very short difference (3 bp) between these 2 major TSS, a technical inaccuracy rather than the actual presence of 2 separate TSS is a likely explanation. By use of diacritic PCR, we further mapped a third TSS, tissue-specifically generated in brain, placenta, spleen, and prostate. 24 It is conceivable that transcription of the OPG gene is under control of alternative promoters, activated by tissue-specific TFs. Even if transcription, started at the different TSS of the OPG gene, does not result in an alteration of the amino acid composition of the protein per se, mRNA isoforms with heterogeneous 5ЈUTR are generated, which may influence transcript stability or translation efficiency.
To define promoter portions being involved in OPG transcriptional activity, we designed serial deletion constructs; these analyses being also useful to mimic the impact of physical inactivation of DNA portions by nuclear histone packaging. Whereas the full-length construct Del1 (Ϫ1020/ Ϫ13) displayed a sufficient transcriptional activity, 5Јtruncation of 85 bp (Ϫ936/Ϫ13) resulted in a complete abrogation of activity. In contrast to haplotypes estimated by maximum likelihood method of inference or other tools, MolHaps are inferred from subcloning of individual DNA providing the allelic constellation in a given DNA strand. 17 Introduction of the MolHaps and the proximal T-159C variant in the context of the full-length construct decreased transcriptional activities significantly. Occurrence of the Ϫ159C allele in the context of the truncated constructs Del2, Del3, and Del4 revealed a distinct and significant increase of transcriptional activity.
These results suggest the presence of a cis-regulatory element within the truncated 85 bp at position Ϫ1020/Ϫ936, which interacts with the T-159C site. EMSA experiments revealed an allele-specific binding of Egr1 to the Ϫ159T allele. By use of ChIP assays, we demonstrated binding of Egr1 to T-159C in U2Os and Sp1 in SaOs-2 cells; binding of NF-1 was detected in both cell lines. In accordance with our transfection analyses, Egr1 seemed to act as a repressor of OPG transcription in the context of the truncated constructs. This repressing feature was absent in the context of the full-length construct. We suppose that an interaction of Egr1 with a TF bound within the truncated 85 bp (Ϫ1020/Ϫ936) may be responsible for this observation. To confirm this hypothesis, we performed a "reverse" experiment: the isolated OPG MolHaps (Ϫ1020/Ϫ772) did not display tran-scriptional activities over the empty vector, indicating an apparent interaction between the distal and the proximal promoter portion, being indispensable for transcriptional activation.
Cis-active elements exert transcriptional activity by interaction with TFs that assemble at the promoter as modules, 25 the composition of an individual module being cell type-and context-specific. For OPG, we propose a hypothetical transcriptional module ( Figure 6B ): (I) Sp1, NF-1, and NF-B bind to the MolHap portion, and interact with Egr1 (Ϫ159T allele) to cooperatively stimulate transcription; (II) The Ϫ159C allele leads to a loss of the TFBS for Egr1, the transcriptional module is altered and transcriptional activity is decreased; (III) Truncation leads to a loss of TFBS for Sp1, NF-1, and NFB, whereas Egr1 alone seems to act as a repressor; (IV) Introduction of the Ϫ159C allele into the truncated constructs results in a partial restoration of transcriptional activity.
Under these modular conditions, genetic variation may gain a pronounced tissue-specific impact on OPG transcript levels. With respect to TF interactions, Egr1 and RelA (p65) cooperatively stimulate NFB1 (p50) gene transcription, 26 Chapman and Perkins 27 reported an interaction of RelA (p65) with the zinc-finger domain of Egr1, repressing transcriptional activity of RelA, possibly by sequestering RelA from its target promoter.
Sp1 and Egr1 share a similar binding site and compete, dependent on the physiological state of a cell, for binding at the cognate sites. Egr1 has been reported to act as a repressor of a constitutively expressed collagen gene by preventing interactions between Sp1 and the general transcriptional machinery. 28 Members of the NF-1 family play important roles in mammary gland function and development. Sequence analyses led to the identification of NF1/A, NF1/B, NF1/C, NF1/L and NF1/X. 29, 30 NF1/X, for example, was shown to specifically interact with Sp1 and block Sp1 induction of the PDGF A-chain promoter. 31 Therefore, interaction of NF-1 with Sp1 may possibly be responsible for the abrogation of transcriptional activities of MolHap2 and MolHap4, even though in silico analyses predicted NF-1 binding site solely for MolHap4 (putative Sp1 was predicted for MolHap1). As in silico analyses cannot integrate the impact of protein:protein interactions on the recruitment of factors to a transcriptional module, further experiments using RNAi, targeting TFs involved, might be useful to cross-check our present findings and help determine putatively altered binding units.
In conclusion, in the present analysis we propose new structural features and the existence of differentially functional portions, interacting with one another within the OPG promoter region. Further, we identified and functionally and structurally characterized different MolHaps and SNPs within the OPG promoter, which might importantly contribute to an understanding of the molecular basis of interindividually different OPG transcriptional regulatory aspects, including control of OPG tissue expression, plasma levels, and predisposition to CVD phenotypes. 
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